| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 |
# |
Score |
Template |
Links and tools | %id | First |
PYEDLLRKILAEGTHKDDRTGTGTTSLFGAQMRFNLAEYFPLITTKKVHFKSIVGELLWFLRGDSNVAFLHENGVTIWDEWADENGDLGPVYGVQWRSWPTPDGRHIDQIAQAIETLKHNPDSRRNIVSAWNVSEISNMALPPCHLLFQLYVADGKLSCQLYQRSADMFLGVPFNIASYALLTHMLAQQAGLEVGEFIWTGGDCHIYDNHREQVELQLTREPRPYPQLKLAKADSIDAYTFADIEVVSYDPHPLIRGAVAV | Last |
1 | -123.000 | PF00303.19; W5XZY7_9CORY/9-269; Thymidylate synthase |
ali |
100 | 1 | PYEDLLRKILAEGTHKDDRTGTGTTSLFGAQMRFNLAEYFPLITTKKVHFKSIVGELLWFLRGDSNVAFLHENGVTIWDEWADENGDLGPVYGVQWRSWPTPDGRHIDQIAQAIETLKHNPDSRRNIVSAWNVSEISNMALPPCHLLFQLYVADGKLSCQLYQRSADMFLGVPFNIASYALLTHMLAQQAGLEVGEFIWTGGDCHIYDNHREQVELQLTREPRPYPQLKLAKADSIDAYTFADIEVVSYDPHPLIRGAVAV |
261 |
2 | -6.940 | PF05995.12; Q1DDT5_MYXXD/3-167; Cysteine dioxygenase type I |
ali follow.. |
10 | 16 | ..............................................................................................LLGWPLPEQTEDIVSMAWLVERLRSSRVD-ELLLVSWLPGQASRVHDHGGSGGA-SWLVRGMLRETRFAWAGDRLVPEVIVGANEGDLLVEFPDTIHRIDNASRHGAVSLHLYAPPMQGMTPY............................................ |
162 |
3 | -6.490 | PF17083.5; SWM2_VANPO/14-144; Nucleolar protein Swm2 |
ali follow.. |
14 | 4 | .................................................................................................................FRDSPVLLKEYGPYLSYHNDGELSLNAVRICEELFDWQNGDHTIAKEVVQCALDMWFGEEYDLKGFEYIPNLIIQEIDVAKGKNTGEIHRIEFHPSTNEPIDEPLN------------------NLILEEVEVHDF............ |
130 |
4 | -6.370 | PF14496.6; Q886T4_PSESM/1702-1922; C-terminal novel E3 ligase, LRR-interacting |
ali follow.. |
10 | 52 | ...........................................................................................................ERVWTVLATANQDPQLCMTLNAIAEEPLRLFHDNATCSDGIVLEFNQMEVLIFTRQSLQNVLYQLAVRLYRLSELDAAAREQAG--------DRDEAEVRLAYRVHWASALN--PVPPEHMLFEVHARIRPGELDTARVRTGEQGEPFLSFAA. |
205 |
5 | -6.340 | PF06040.11; Q8UY74_9ADEN/13-145; Adenovirus E3 protein |
ali follow.. |
16 | 1 | ................................................................................................................IKAETATTPDFRVSKLQLFQPPGTYQCVSGPCHHTFHLI-RRDLSESNTTTHTGGELRGQPTSGIYYGPWEVVGLITLGLVAGGLLVL---CYLY...................................................... |
112 |
6 | -5.980 | PF13743.6; U5L7Y1_9BACI/27-219; Thioredoxin |
ali follow.. |
14 | 75 | .....................................................................................................................................ENPVSSPHLASIAIKAAELQGRKAGIRFLRKLQEVLFLEKQNISNFDVLKS-CAQNVGLDVVEFVADIHSDSAAKAFQCDLKITSEMDVQEIPTLVFFNENI----EEEGIKVTGYYPYEVYV..... |
192 |
7 | -5.950 | PF04473.12; Q5JHU4_THEKO/395-551; Transglutaminase-like domain |
ali follow.. |
15 | 1 | ........................................................................................................EKLRTVTKDFTKYSTTLDKAWAILE-WIDENIEYEYTKADYVDALVYNWSKLTSEQKELYDNLTRLYAPNDIIDYAILTAAMLLDSGVSLDISFENSKVGHAAV..................................................... |
115 |
8 | -5.870 | PF08030.12; RBOHF_ARATH/746-927; Ferric reductase NAD binding domain |
ali follow.. |
10 | 15 | PFISILKDLLNN---IVKMEEHADSISDFSRSSEYSTGSNGDTPRRKRILKTTNAYFYWVTREQGSFDWFKGVMNEVAELDQRAKNGVDIVSGTRVRTHFAR-----PNWKKVLTKLSSKHCNARIGVFYCGVPVLGKELSKLCN.................................................................................................................... |
182 |
9 | -5.840 | PF01085.18; W5MLT6_LEPOC/24-184; Hedgehog amino-terminal signalling domain |
ali follow.. |
17 | 81 | ...........................................................................................................DCVNALAIAVMNQPGVRLRVTEGWDEDGHHPPN-----------------SLHYEGRAVDITTS-DRDPRKYGTLAQ-LAVEAGFD---WVYYESKSHVH...................................................... |
159 |
10 | -5.750 | PF10481.9; G7NUK3_MACFA/1-307; Cenp-F N-terminal domain |
ali follow.. |
11 | 18 | ........................................................................................................QKIQELEGQLDKLKKEKQQRQFQLDSLEAALQKQKQ----------KVENEKTEGTNLKRENQ---RLMEICESLEKTKQKISHELQVKESQ-------VNFQEGQLNSGKKQIEKLEQELKRCKSELERSQQAAQSADVSLNPCS........... |
143 |